Colorectal cancer screening in Canada: Monitoring and evaluation of quality indicators – Results report 2011 to 2012 (Released: 2014)

Review this 2014 report for provincial data about the quality of colorectal cancer screening programs in 2011 and 2012

This report focuses on quality indicators for programmatic colorectal cancer screening. Increased programmatic screening protects Canadians from developing or dying from colorectal cancer. Programmatic screening also encourages comprehensive monitoring and evaluating to make sure the screening services are high quality.

This report presents the results for national monitoring of colorectal cancer screening programs for 2011 and 2012, including the following information:

  • A review of the current state of population-based colorectal cancer screening programs that exist in provinces and territories across Canada
  • An update on key quality indicators and targets achieved by the various jurisdictions which submitted data
  • A closer look at what happens after an abnormal fecal test result, including wait times for a follow-up colonoscopy
  • A brief synopsis of what lies ahead in colorectal cancer screening from the perspective of individual provinces and territories

Colorectal cancer is the third-leading incident cancer and the second leading cause of cancer death in Canada, with an estimated 24,400 new cases and 9 300 deaths in 2014. The rate of colorectal cancer has been declining since 2001. However, Canada has one of the highest age-standardized rates of colorectal cancer in the world. Colorectal cancer can occur at any age, but approximately 93 per cent of new cases occur in men and women aged 50 years or older. The number of colorectal cancer deaths continues to decline for both males and females.

Downloadable content